Demographics | |
---|---|
Age (years) | 59.4 ± 15.4 |
Male | 159 (57.8%) |
Female | 116 (42.2%) |
Ethnicity | |
White | 179 (65.1%) |
Black | 65 (4.4%) |
Hispanic | 12 (1.5%) |
Unknown | 11 (23.6%) |
Asian | 4 (4%) |
Height | 169.7 ± 12.3 cm |
Weight | 86 ± 28.1 kg |
BMI (overall) | 30 ± 8.8 (kg/m2) |
< 18.5 (underweight) | 12 (4.4%) |
18.5–24.9 (normal) | 73 (26.5%) |
25–29.9 (overweight) | 85 (30.9%) |
30–34.9 (moderate obese) | 50 (18.2%) |
35–39.9 (severely obese) | 23 (8.4%) |
≥ 40 (very severely obese) | 32 (11.6%) |
ASA classification on admission | 3.6 ± 0.5 |
ASA 1 | 1 (0.3%) |
ASA 2 | 4 (1.5%) |
ASA 3 | 94 (34%) |
ASA 4 | 176 (64%) |
ASA 5 | 0 (0%) |
Comorbidity on admission | |
Hypertension | 163 (48.5%) |
Sepsis | 99 (29.5%) |
Hyperlipidemia | 87 (25.9%) |
Malignancy | 87 (25.9%) |
Diabetes | 78 (23.2%) |
Chronic kidney disease | 74 (22%) |
Coronary artery disease | 62 (18.5%) |
Atrial fibrillation | 50 (14.9%) |
Congestive heart failure | 47 (14%) |
Cerebrovascular accident | 47 (14%) |
Acute hepatic failure | 42 (12.5%) |
Hemodialysis | 38 (11.3%) |
Myocardial infarction | 36 (10.7%) |
Seizure | 34 (10.1%) |
Hepatic encephalophaty | 34 (10.1%) |
Anticoagulation (active) | 33 (9.8%) |
Chronic obstructive lung disease | 32 (9.5%) |
Pulmonary embolism (history) | 31 (9.2%) |
Pulmonary hypertension | 31 (9.2%) |
Gastroesophageal reflux disease | 30 (8.9%) |
Obstructive sleep apnea | 17 (5.1%) |
Pulmonary embolism (actively) | 16 (4.8%) |
Asthma | 11 (3.3%) |